Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells
- 23 March 2006
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 249 (1-2) , 116-122
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Possible Pathomechanisms of Sudden Infant Death SyndromeAmerican Journal of Therapeutics, 2004
- Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cellsRegulatory Peptides, 2004
- An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6European Journal of Cancer, 2004
- Protein Kinase C ζ Transactivates Hypoxia-Inducible Factor α by Promoting Its Association with p300 in Renal CancerCancer Research, 2004
- Hypoxia-inducible Factor and Its Biomedical RelevanceJournal of Biological Chemistry, 2003
- Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptorsCellular Signalling, 2001
- VIP Gene Transcription Is Regulated by Far Upstream Enhancer and Repressor ElementsBiochemical and Biophysical Research Communications, 2001
- Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factorsKidney International, 1997
- Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial CellsJournal of Biological Chemistry, 1995